Advertisement

Topics

Sutro and Celgene to Refocus 2014 Immuno-Oncology Collaboration on Four Programs

05:25 EDT 11 Aug 2017 | PharmPro

Under a newly modified agreement, Celgene can acquire worldwide rights to a second collaboration program and Sutro will retain U.S. development and commercialization rights.
Contributed Author: 
Sutro Biopharma

Original Article: Sutro and Celgene to Refocus 2014 Immuno-Oncology Collaboration on Four Programs

NEXT ARTICLE

More From BioPortfolio on "Sutro and Celgene to Refocus 2014 Immuno-Oncology Collaboration on Four Programs"

Quick Search
Advertisement
 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...